Antidepressants and the Serotonin Hypothesis

A major 2022 review concluded there is no convincing evidence that depression is caused by low serotonin — raising questions about the scientific basis for SSRIs, the world's most prescribed psychiatric drugs.

Dossier

Established

The serotonin hypothesis posits a link between low serotonin levels and depression, a view largely supported by mainstream medical literature and clinicians advocating for SSRIs. A 2022 review cast doubt on this hypothesis, finding no convincing evidence that low serotonin causes depression.

Alleged

Dissenting experts claim that the effects of SSRIs may be attributable to placebo effects, challenging the notion that they directly influence serotonin levels. Critics argue that financial interests may bias research outcomes, suppressing studies that contradict the serotonin model.

Still open

The relationship between serotonin and depression, including the potential efficacy of SSRIs versus non-pharmacological interventions, remains inadequately resolved.

Who profits

The pharmaceutical industry benefits substantially from the continued prescription of SSRIs, as they are among the most widely prescribed medications globally. Additionally, healthcare systems that rely on pharmacological treatment may resist exploring alternative therapies that could disrupt established practices.

ENZØ observation

The serotonin hypothesis persists despite mounting criticism. A 2022 review dismantles its foundations, yet the consensus remains largely unshaken. Pharmaceutical interests are interwoven throughout the narrative, overshadowing dissenting voices. The efficacy of SSRIs is defended while alternative treatments linger in obscurity, underutilized. Why does a model so central to psychiatric practice face such resistance? The complex dance of profit and patient care feels unsettlingly choreographed. Missing links persist; the silence around systemic biases underscores the urgency for clarity.

// anomaly.echo: when profit eclipses evidence, shadows grow longer.

Verdict

While the role of serotonin in depression remains a topic of contention, it is clear that the understanding of mental health is evolving. This controversy highlights the need for more nuanced research into the biological and psychosocial factors at play. Readers should consider exploring both mainstream and alternative theories and the implications of financial interests in this discourse.